Researchers develop techniques to track the activity of a potent cancer gene

March 01, 2019

BALTIMORE, MD - MYC is one of the most potent cancer genes, contributing to almost every kind of cancer--yet it is still not known how it causes tumors to form. Though higher levels of MYC are present in a wide range of tumor types, MYC alone does not usually lead to tumors. Simona Patange, a Ph.D. candidate in biophysics with the UMD-NCI Partnership for Integrative Cancer Research in Daniel Larson's lab at the National Cancer Institute, is using novel tools to track MYC and its activity in individual cells. Patange will present their latest developments at the 63rd Biophysical Society Annual Meeting, to be held March 2 - 6, 2019 in Baltimore, Maryland.

MYC is a transcription factor, meaning it activates other genes leading them to transcribe more RNA that drives other cell processes, including growth and division. For a long time it was assumed that MYC turned on a set of target genes that lead to cancer. However, in recent years, scientists learned that all genes are responsive to MYC.

"MYC is like a volume knob for gene transcription--it doesn't turn genes on, but it does turn up the activity of genes that are already active," Larson explained.

To see how MYC's changes in gene expression might lead to tumors, Patange and colleagues employed recently-developed imaging techniques to look at the RNA produced from gene transcription in individual cells. They noticed that cells with extra MYC had a global increase in RNA, and also that there were subtle differences in gene transcription between cells.

"The fact that MYC allows more gene expression and can lead to minute differences in RNA levels between cells might allow an individual cell to go down a path towards cancer," Patange said.

One difficulty with studying MYC is that it's always working to turn on genes, so it's hard to decipher if it has a preference for certain genes or to know how much RNA message is transcribed from those genes. To address that challenge, Patange and colleagues engineered a version of MYC that uses light to control its physical location in the cell, and has oncogenic capacity like normal MYC. Now they will be able to control when MYC enters and exits the nucleus and see what genes immediately respond, and how much message those genes go on to produce.

"Now we have a system where we can precisely look at how genes are being transcribed in response to MYC, that's a major advance," Larson said.

They hope this new toolkit will allow them to reveal precisely how MYC drives cancer.
-end-
The Biophysical Society, founded in 1958, is a professional, scientific Society established to encourage development and dissemination of knowledge in biophysics. The Society promotes growth in this expanding field through its annual meeting, monthly journal, and committee and outreach activities. Its 9,000 members are located throughout the U.S. and the world, where they teach and conduct research in colleges, universities, laboratories and government agencies. http://www.biophysics.org.

Biophysical Society

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.